Phase I combination dose-finding/phase II expansion cohorts of lenvatinib + etoposide + ifosfamide in patients (pts) aged 2 to ≤ 25 years with relapsed/refractory (r/r) osteosarcoma
暂无分享，去创建一个
B. Morland | S. Bielack | S. Strauss | F. Locatelli | E. Thébaud | C. Rossig | A. Longhi | N. Entz-Werlé | M. Casanova | R. Venkatramani | Q. Campbell-Hewson | M. Gambart | I. Aerts | N. Gaspar | P. M. Bérard | C. He | C. Lervat | F. Sirvent | S. G. Melcon | A. Nieto | E. Thebaud